CA2006496A1 - Composes g-43 de mammniferes et methode d'utilisation - Google Patents

Composes g-43 de mammniferes et methode d'utilisation

Info

Publication number
CA2006496A1
CA2006496A1 CA002006496A CA2006496A CA2006496A1 CA 2006496 A1 CA2006496 A1 CA 2006496A1 CA 002006496 A CA002006496 A CA 002006496A CA 2006496 A CA2006496 A CA 2006496A CA 2006496 A1 CA2006496 A1 CA 2006496A1
Authority
CA
Canada
Prior art keywords
gap
cells
cell
protein
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002006496A
Other languages
English (en)
Inventor
Mark C. Fishman
Howard J. Federoff
Mauricio X. Zuber
Stephen M. Strittmatter
Dario Valenzuela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2006496A1 publication Critical patent/CA2006496A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/61Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002006496A 1988-12-22 1989-12-22 Composes g-43 de mammniferes et methode d'utilisation Abandoned CA2006496A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US28860488A 1988-12-22 1988-12-22
US288,604 1988-12-22
US30523989A 1989-02-02 1989-02-02
US305,239 1989-02-02
US40140889A 1989-09-01 1989-09-01
US401,408 1989-09-01

Publications (1)

Publication Number Publication Date
CA2006496A1 true CA2006496A1 (fr) 1990-06-22

Family

ID=27403823

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002006496A Abandoned CA2006496A1 (fr) 1988-12-22 1989-12-22 Composes g-43 de mammniferes et methode d'utilisation

Country Status (6)

Country Link
EP (1) EP0407543A4 (fr)
JP (1) JPH03504017A (fr)
KR (1) KR910700258A (fr)
AU (1) AU4841990A (fr)
CA (1) CA2006496A1 (fr)
WO (1) WO1990006948A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002749A1 (fr) * 1989-08-21 1991-03-07 Cetus Corporation PEPTIDES DERIVES DE LA PROTEINE D'ACTIVATION DE GTPase (PAG) AINSI QUE LEURS EMPLOIS DIAGNOSTIQUE ET THERAPEUTIQUE
WO1993006851A1 (fr) * 1991-10-11 1993-04-15 The General Hospital Corporation Compositions de gap-43 d'origine mammifere et procede d'utilisation
EP0673385A4 (fr) * 1992-08-13 1995-11-29 Gen Hospital Corp Compositions concernant gap-43 des mammiferes et procedes d'utilisation.

Also Published As

Publication number Publication date
KR910700258A (ko) 1991-03-14
AU4841990A (en) 1990-07-10
JPH03504017A (ja) 1991-09-05
EP0407543A4 (en) 1992-10-14
EP0407543A1 (fr) 1991-01-16
WO1990006948A1 (fr) 1990-06-28

Similar Documents

Publication Publication Date Title
US20030100745A1 (en) Antibody for 4-1BB
WO1992018138A1 (fr) Compositions et methodes d'utilisation de gap-43 de mammifere
Devlin et al. Secretion of a soluble class I molecule encoded by the Q10 gene of the C57BL/10 mouse.
EP1007074B1 (fr) Polypeptides specifiques de l'hypothalamus
WO1994017184A1 (fr) Modulation de la reponse physiologique de lymphocytes par les molecules cd38 ou leurs anti-corps
WO1994004562A1 (fr) Compositions concernant gap-43 des mammiferes et procedes d'utilisation
WO1994004562A9 (fr) Compositions concernant gap-43 des mammiferes et procedes d'utilisation
US5753502A (en) Neuron-specific ICAM-4 promoter
JP3779989B2 (ja) リンパ抗原cd30
MXPA01011264A (es) Nuevos polipeptidos de eritropoyetina de chimpance (chepo) y aciodos nucleicos que codifican los mismos.
US20090061480A1 (en) Nucleotide sequence encoding a modulator of nf-kb
CA2167303A1 (fr) Regulation du facteur de transcription nf-il6/lap
CA2006496A1 (fr) Composes g-43 de mammniferes et methode d'utilisation
JPH03155787A (ja) Ebzd蛋白質発現系
RU2186783C2 (ru) Кроличья антисыворотка, ингибирующая транспорт катионных аминокислот, и содержащая ее фармацевтическая композиция
US5770686A (en) ICAM-related protein fragments
WO1998033819A1 (fr) Recepteurs cellulaires des adenovirus du sous-groupe c et des virus coxsackie du groupe b
WO1998033819A9 (fr) Recepteurs cellulaires des adenovirus du sous-groupe c et des virus coxsackie du groupe b
US6429010B1 (en) DNA encoding the human synapsin III gene and uses thereof
EP1308514A2 (fr) ICAM-4 matériaux et procédures
US20090130112A1 (en) Spatial for altering cell proliferation
US5831051A (en) Receptor for peptide hormones involved in energy homeostasis, and method and compositions for use thereof
US6071741A (en) Doc tumor suppressor protein and gene
WO1994004567A9 (fr) Proteine d'adn a association matricielle, acides nucleiques encodant celle-ci et procede pour detecter les acides nucleiques
US20040101528A1 (en) Type I IL-1 receptors

Legal Events

Date Code Title Description
FZDE Dead